Salvia miltiorrhiza and ischemic diseases

Citation
Xy. Ji et al., Salvia miltiorrhiza and ischemic diseases, ACT PHAR SI, 21(12), 2000, pp. 1089-1094
Citations number
44
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ACTA PHARMACOLOGICA SINICA
ISSN journal
02539756 → ACNP
Volume
21
Issue
12
Year of publication
2000
Pages
1089 - 1094
Database
ISI
SICI code
0253-9756(200012)21:12<1089:SMAID>2.0.ZU;2-#
Abstract
The demonstration of beneficial effects of salvia miltiorrhiza (DanShen) on ischemic diseases has revolutionized the management of angina pectoris, my ocardial infarction (MI) or stroke in Chinese society. Experimental studies have shown that DanShen dilated coronary arteries, increased coronary bloo d flow, and scavenged free radicals in ischemic diseases, so that it reduce d the cellular damage from ischemia and improved heart functions. Clinical trials also indicated that DanShen was an effective medicine for angina pec toris, MI, and stroke. This review will focus on DanShen's effects in angin a pectoris, MI and stroke.